APLS
APLS
NASDAQ · Biotechnology

Apellis Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$41.03
+0.02 (+0.05%)
As of May 9, 1:25 AM ET ·
Analyst Consensus
Hold
27
Analysts
High
Coverage
Buy 8 30%
Hold 19 70%
Sell 0 0%
Price Target
Analyst Price Target -45.1% upside
Low Target $12.93
Average Target $22.54
High Target $29.12
Current Price $41.03
Current
$41.03
Target
$22.54
$12.93 $22.54 avg $29.12
Scenario Analysis
Bear Case
$12.93
-68.5%
Low target
Base Case
$22.54
-45.1%
Avg target
Bull Case
$29.12
+-29.0%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$41.14
-0.3% from high
52-Week Low
$16.10
+154.8% from low
50-Day SMA
$23.47
+74.8% vs SMA
200-Day SMA
$22.25
+84.4% vs SMA
RSI (14)
47.9
Neutral
Target vs 52W High
$22.54
-45.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%